Abstract
Intravenous infusion of a high-K+ solution (67.5 mM KCl, 67.5 mM NaCl) to anesthetized rats increased urine volume by 47.6% after 60 min, compared with infusion of a Na+ solution (135 mM NaCl). This treatment also increased urinary excretion of Na+ by 32.2%, in parallel with an increase in excretion of K+ or Cl-. Urinary excretion of kallikrein increased within 60 min after the start of K+ infusion. A bradykinin B2 receptor antagonist, 8-[3-[N-[(E)-3-(6-acetamidopyridin-3-yl)acryloylglycyl]-N-methylamino]-2,6-dichlorobenzyloxy]-2-methylquinoline (FR173657; 1.0 mg/kg, i.v.), inhibited the K+-induced diuresis and natriuresis by 41.0% and 26.7%, respectively. These results indicate that K+ load induces diuresis and natriuresis through the renal kallikrein-kinin system in rats. Copyright (C) 2000 Elsevier Science B.V.
| Original language | English |
|---|---|
| Pages (from-to) | 223-227 |
| Number of pages | 5 |
| Journal | European Journal of Pharmacology |
| Volume | 399 |
| Issue number | 2-3 |
| DOIs | |
| Publication status | Published - 7 Jul 2000 |
Keywords
- Bradykinin B receptor antagonist
- Diuresis
- FR173657
- K
- Kallikrein secretion
- Natriuresis